Skip to main content
. 2020 Oct 6;4(19):4812–4821. doi: 10.1182/bloodadvances.2020002204

Table 2.

Cox models for OS, DFS, NRM, and relapse

Variable HR 95% CI P
OS
 TERS score
  30-37.5 vs ≤29.5 1.50 1.05-2.14 .028
  ≥38 vs ≤29.5 1.42 1.02-2.06 .049
 Age, y
  ≥55 vs <55 1.94 1.45-2.59 <.001
 Disease risk
  Intermediate vs low 1.39 0.99-1.95 .056
  High vs low 1.68 1.10-2.58 .018
 Year of transplantation
  2010-2014 vs 2003-2009 0.67 0.46-0.96 .029
  2015-2017 vs 2003-2009 0.56 0.35-0.88 .011
DFS
 TERS score
  30-37.5 vs ≤29.5 1.36 0.99-1.87 .055
  ≥38 vs ≤29.5 1.31 0.95-1.80 .102
 Age, y
  ≥55 vs <55 1.67 1.28-2.17 <.001
 Disease risk
  High vs low 1.74 1.21-2.49 .003
TRM
 TERS score
  30-37.5 vs ≤29.5 1.91 1.14-3.21 .014
  ≥38 vs ≤29.5 1.80 1.07-3.04 .028
 Age, y
  ≥55 vs <55 1.72 1.15-2.56 .008
Relapse
 TERS score
  30-37.5 vs ≤29.5 1.05 0.70-1.57 .820
  ≥38 vs ≤29.5 0.99 0.66-1.49 .950
 Diagnosis
  AML vs other 1.90 1.21-2.98 .005
  ALL vs other 2.33 1.31-4.13 .004
 Disease risk
  High vs low 2.13 1.38-3.27 <.001
Intensity
  Myeloablative vs nonmyeloablative/RIC 0.58 0.40-0.84 .004